Emergence of Bictegravir Resistance in a Treatment-Experienced PWH on Functional Monotherapy and Rapid Replacement by an Ancient Wild-Type Strain Following Transient Treatment Interruption
Viruses · 2025
DOI: 10.3390/v17050699 ↗Kurz gefasst
Fallbericht in der Zeitschrift Viruses, 2025. Verfasst von Pietro B Faré und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, 8091 Zurich, Switzerland. Hauptthemen laut MEDLINE: HIV Infections, HIV-1, Drug Resistance, Viral, Heterocyclic Compounds, 4 or More Rings. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yvonne Jacob Foundation.
Abstract (Originalsprache)
A treatment-experienced, highly adherent person living with HIV for over 25 years developed resistance mutations against all four major ART classes, including bictegravir (BIC). This led to viral failure on a quadruple regimen including BIC and doravirine (DOR). Resistance emergence was associated with M184V, thymidine analog mutations (TAMs), NNRTI mutations (108I, 234I, 318F), and INSTI mutations (T97A, G140S, Q148H, G149A), likely driven by suboptimal BIC levels due to divalent cation interactions. During a two-month ART interruption, the resistant virus was rapidly replaced by an ancient wild-type strain. Despite resistance to all four ART classes, a genotype-adapted salvage regimen, including fostemsavir, achieved viral suppression within seven months.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, 8091 Zurich, Switzerland.
- Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
ORCID-Profile: Pietro B Faré, Judith Bergadà Pijuan, Irene A Abela, Michael Huber, Huldrych F Günthard
Förderung
- Yvonne Jacob Foundation
Zitieren
APA
Faré, P. B., Ziltener, G., Bergadà Pijuan, J., Abela, I. A., Hirsch, B. L., Huber, M., Nemeth, J., & Günthard, H. F. (2025). Emergence of Bictegravir Resistance in a Treatment-Experienced PWH on Functional Monotherapy and Rapid Replacement by an Ancient Wild-Type Strain Following Transient Treatment Interruption. Viruses. https://doi.org/10.3390/v17050699
Vancouver
Faré PB, Ziltener G, Bergadà Pijuan J, Abela IA, Hirsch BL, Huber M, et al. Emergence of Bictegravir Resistance in a Treatment-Experienced PWH on Functional Monotherapy and Rapid Replacement by an Ancient Wild-Type Strain Following Transient Treatment Interruption. Viruses. 2025. doi:10.3390/v17050699
BibTeX
@article{Far2025,
author = {Faré, Pietro B and Ziltener, Gabriela and Bergadà Pijuan, Judith and Abela, Irene A and Hirsch, Britta L and Huber, Michael and Nemeth, Johannes and Günthard, Huldrych F},
title = {Emergence of Bictegravir Resistance in a Treatment-Experienced PWH on Functional Monotherapy and Rapid Replacement by an Ancient Wild-Type Strain Following Transient Treatment Interruption},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17050699}
}
EUVIMED